Third Patient Treated with HG-CT-1 CAR-T Therapy Successfully Passes Initial Safety Evaluation LONDON, UNITED KINGDOM / ACCESS Newswire / September…
- Abstract highlights additional primary and secondary data from Phase 3 STAR-1 clinical study of XYNGARI™ for the treatment of…
Study Sponsored by Optigenex Inc. and conducted by the University of Northern Arizona led by Doctor Oneil Guthrie, demonstrates significant…
WASHINGTON, Sept. 16, 2025 /PRNewswire/ -- Today, PatientRightsAdvocate.org (PRA), released a new Interim Semi-Annual Report exposing hospitals that are leaving consumers without…
Patient Transitions, Communication and Hand-Off Issues are Among the Leading Causes of Safety Incidents in Maternal Care WILLOW GROVE, Pa.,…
Brings Deep Expertise in Healthcare Strategy to Accelerate Jasper's Mission to Improve the Cancer Care Experience BOISE, Idaho, Sept. 16,…
Recognition by Healthcare Tech Outlook underscores Glytec's leadership in hospital insulin management, clinical outcomes, and enterprise scalability BOSTON, Sept. 16,…
TAMPA, Fla., Sept. 16, 2025 /PRNewswire/ -- AnswersMD.com, a rapidly expanding concierge medicine group, today announced the official launch of…
DENVER, CO / ACCESS Newswire / September 16, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical…
HLTH attendees will get the first look at breakthrough automation built to handle healthcare's most complex revenue cycle challenges OAK…